These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11979916)

  • 1. [Recent advances in basic research of bone metabolism].
    Inoue D; Matsumoto T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():25-33. PubMed ID: 11979916
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent advances in the regulation of bone remodeling].
    Matsumoto T
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():37-46. PubMed ID: 15035093
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adhesion molecules in the context with bone remodeling and osteoporosis].
    Tanaka Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():125-30. PubMed ID: 15035110
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recent advance in basic research for osteoporosis].
    Suda T; Miyaura C
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():13-20. PubMed ID: 15035090
    [No Abstract]   [Full Text] [Related]  

  • 5. [Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?].
    Ferrer Cañabate J; Tovar I; Martínez P
    An Med Interna; 2002 Aug; 19(8):385-88. PubMed ID: 12244784
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recent advances in research of bone resorption].
    Inoue D
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():48-56. PubMed ID: 11979946
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of PPAR gamma for the osteoblastic differentiation].
    Takeda S; Takeuchi Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():789-93. PubMed ID: 15035228
    [No Abstract]   [Full Text] [Related]  

  • 8. [Crosstalk between the immune and skeletal system].
    Takayanagi H
    Ryumachi; 2003 Oct; 43(4):624-31. PubMed ID: 14598653
    [No Abstract]   [Full Text] [Related]  

  • 9. [Regulatory mechanism of osteoclast differentiation and function].
    Okumura S; Udagawa N; Takahashi N
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():90-6. PubMed ID: 15035103
    [No Abstract]   [Full Text] [Related]  

  • 10. [OPG(osteoprotegerin)/OCIF(osteoclastogenesis inhibitory factor)].
    Inoue D
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():102-6. PubMed ID: 15035105
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulatory mechanisms of osteoblast and osteoclast differentiation.
    Katagiri T; Takahashi N
    Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cytokine system of bone tissue].
    Stilgren LS; Abrahamsen B; Abdallah BM; Jørgensen NR
    Ugeskr Laeger; 2005 Feb; 167(8):874-8. PubMed ID: 15789838
    [No Abstract]   [Full Text] [Related]  

  • 14. [Osteoclastogenesis Inhibitory Factor (OCIF) /Osteoprotegerin (OPG) as a new therapeutic agent for osteoporosis].
    Mochizuki S; Kiyokawa A; Nagayama Y
    Clin Calcium; 2005 Jan; 15(1):35-42. PubMed ID: 15632471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progress of bone cell culture system (review)].
    Koshihara Y
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():79-87. PubMed ID: 11979973
    [No Abstract]   [Full Text] [Related]  

  • 16. [Osteoclast function is regulated by neighbouring osteoblasts. Osteoprotegerin, RAND and RANK ligand constitute a unique regulatory system for bone resorption with important pathophysiological and therapeutic aspects].
    Ueland T; Bollerslev J; Mosekilde L
    Ugeskr Laeger; 2002 Jul; 164(27):3526-30. PubMed ID: 12116680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteoclastogenesis inhibitory factor/osteoprotegerin(OCIF/OPG)].
    Tomoyasu A; Higashio K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():560-5. PubMed ID: 15035190
    [No Abstract]   [Full Text] [Related]  

  • 18. [Osteoprotegerin ligand and osteoprotegerin: new concepts of the pathogenesis and therapy of metabolic bone diseases].
    Hofbauer LC; Heufelder AE
    Dtsch Med Wochenschr; 2001 Feb; 126(6):145-50. PubMed ID: 11233883
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone metabolism and growth hormone deficiency. Experimental and clinical aspects.
    Ueland T; Bollerslev J
    Front Horm Res; 2005; 33():146-160. PubMed ID: 16166760
    [No Abstract]   [Full Text] [Related]  

  • 20. [LPS].
    Miyaura C
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():116-9. PubMed ID: 15035108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.